Oxford, UK 16 July 2013. Oxford Gene Technology (OGT), provider of innovative genetics research and biomarker solutions to advance molecular medicine, has produced a new, free-to-download whitepaper titled ŒWhen to use targeted resequencing ‹ Choosing the right NGS method.¹ The paper aims to assist researchers when planning NGS strategies by providing a detailed review of the major resequencing methods. Comparing and contrasting method suitability, the paper also examines the significant impact of data analysis, as well as time and cost considerations. OGT has written the whitepaper in response to a growing demand from within its customer base and the NGS community for a balanced and comprehensive guide to targeted resequencing strategies.
Considered from both clinical research and discovery viewpoints, the paper discusses whole exome and targeted panel sequencing strategies, without bias. This includes highlighting the limitations of each approach, and offering advice on when whole genome sequencing is appropriate, providing researchers with insight to identify the most suitable method for the task at hand. Considerations are also presented on choice of capture technologies, bait design and the use of service providers for method optimisation and accessibility to meaningful results.
To learn more about targeted resequencing methods, download the whitepaper. To find out more about OGT¹s Genefficiency Sequencing Services, visit the OGT websiteor contact us at [email protected]
For further information, please contact:
Oxford Gene Technology,
Begbroke Science Park,
OX5 1PF, U.K.
T: +44 (0) 1865 856826
F: +44 (0) 1865 848684
E: [email protected]